nitroflurbiprofen has been researched along with Inflammation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caniglia, S; Impagnatiello, F; L'Episcopo, F; Marchetti, B; Morale, MC; Serra, PA; Testa, N; Tirolo, C | 1 |
| Caniglia, S; Impagnatiello, F; L'episcopo, F; Marchetti, B; Morale, MC; Testa, N; Tirolo, C | 1 |
| Kadish, I; van Groen, T | 1 |
| Gasparini, L; Morgan, D; Ongini, E; Wilcock, D | 1 |
| Bhatia, M; Huang, J; Moochhala, SM; Moore, PK | 1 |
1 review(s) available for nitroflurbiprofen and Inflammation
| Article | Year |
|---|---|
Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Flurbiprofen; Humans; Inflammation; Microglia; Structure-Activity Relationship | 2005 |
4 other study(ies) available for nitroflurbiprofen and Inflammation
| Article | Year |
|---|---|
Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Flurbiprofen; Humans; Inflammation; Macrophage-1 Antigen; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidoreductases; Parkinson Disease; Rotarod Performance Test; Substantia Nigra; Tyrosine | 2010 |
Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice.
Topics: Aging; Animals; Dopaminergic Neurons; Flurbiprofen; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Nerve Regeneration; Nitrosation; Oxidative Stress; Phenotype; Real-Time Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase | 2011 |
Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
Topics: Acetylcholinesterase; Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Butyrylcholinesterase; CD11b Antigen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Flurbiprofen; Fornix, Brain; Glial Fibrillary Acidic Protein; Hippocampus; Histocytochemistry; Inflammation; Male; Membrane Transport Proteins; Mice; Mice, Transgenic; Oligopeptides; Ovariectomy; Random Allocation; Vesicular Acetylcholine Transport Proteins | 2005 |
Flurbiprofen and HCT1026 protect mice against acute pancreatitis-associated lung injury.
Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Flurbiprofen; Gastric Mucosa; Inflammation; Lung; Lung Injury; Male; Mice; Neutrophils; Nitric Oxide; Pancreas; Pancreatitis; Peroxidase; Sepsis; Time Factors | 2005 |